関連する実験動画

Updated: May 11, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.5K

オラパリブ,テモゾロミド,オクサリプラチンによるインビトロ再定位療法: U118,U87,U251,H4およびヒト線維芽細胞

Anna Zając-Grabiec1, Anna Czopek2, Karolina Pazdan3

  • 1Department of Medical Physics, Cyclotron Centre Bronowice, Institute of Nuclear Physics, Polish Academy of Sciences, Radzikowskiego 152, Kraków, 31-342, Poland. anna.zajac-grabiec@ifj.edu.pl.

Pharmacological reports : PR
|September 3, 2025
PubMed
まとめ

再利用薬であるオラパリブとオキシリプラチンは,テモゾロミドと併用して,アグレッシブグリオブラストーママルチフォーム (GBM) の脳腫瘍の治療に有望であることが示されています. この多剤化学療法戦略は,がん細胞の生存能力を効果的に低下させ,細胞死をインビトロで誘導します.

キーワード:
グリオブラストーマ・マルチフォームマルチドラッグの位置変更オラパリブオキシリプラチンテモゾロミド

さらに関連する動画

Evaluating In Vitro DNA Damage Using Comet Assay10:43

Evaluating In Vitro DNA Damage Using Comet Assay

Published on: October 11, 2017

38.1K
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

2.9K

関連する概念動画

Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...